Fund managers have been buying these ASX shares

Fund managers have been buying Marley Spoon AG (ASX:MMM) this month. Here's what you need to know…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I've been keeping a close eye on what substantial shareholders have been doing recently.

Substantial shareholders are shareholders that hold 5% or more of a company's shares. These tend to be large investors, asset managers, and investment funds. These shareholders are obliged to update the market when they make any changes to their holdings.

As a result, I feel investors should look to use these notices to their advantage. After all, they show where the smart money is going.

Two notices that have caught my eye are summarised below:

ASX buy

Marley Spoon AG (ASX: MMM)

According to a change of interests of substantial holder notice, Perennial Value Management has been increasing its stake in this meal kit delivery company. The notice reveals that over the last four weeks the fund manager has picked up just over 2 million Marley Spoon shares. This has increased its holding in the company to approximately 12.5 million shares, which is the equivalent of a 7.88% stake.

Marley Spoon is being seen as a big winner from the pandemic due to more eating at home. This has led to a surge in demand for its meal kit subscriptions, sending its shares hurtling higher. Since this time in March, Marley Spoon's shares have climbed 400%. This fund manager appears to believe its shares can continue climbing higher.

Monash IVF Group Ltd (ASX: MVF)

A notice of initial substantial holder reveals that Challenger Ltd (ASX: CGF) has been buying this fertility treatment company's shares. Over the last six weeks the annuities company has picked up 20,687,831 shares in Monash IVF. This represents a 5.74% stake in the company.

Challenger may believe that recent share price weakness is a buying opportunity now that lockdowns are easing and fertility treatment services are up and running again. The Monash IVF share price is down 60% from its 52-week high.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Share Market News

Testing again

Read more »

Share Market News

Aaron Test 2

Read more »

Share Market News

Aaron Test

Read more »

Share Market News

JP Test

Read more »

Share Market News

JP Test

Read more »

Portrait of Discovery Fund portfolio managers Mark Devcich and Chris Bainbridge
Share Market News

Test

Portfolio managers Mark Devcich (left) and Chris Bainbridge. Image source: Discovery Fund test test

Read more »

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.
Share Market News

Another ASX 200 company has been hit with a cyber incident. Here's what we know

Hackers have breached the systems of this ASX 200 company.

Read more »

a woman
Broker Notes

5 ASX 200 shares that inflation can't touch: expert

Regardless of whether you're a bull or a bear, cost pressures are a factor when buying stocks at the moment.

Read more »